Braylon Taylor
Pronouns: she/her/hers
Research Mentor(s): Ulka Vaishampayan
Research Mentor School/College/Department: Internal Medicine, Hem/Oncology / Medicine
Program:
Authors: Ulka Vaishampayan, Braylon Taylor, Sara Garcia
Session: Session 2: 10:00 am – 10:50 am
Poster: 60
Abstract
While progress has been made in the cancer screening process, many women still face challenges in their efforts to be diagnosed early with breast cancer. Mammograms are uncomfortable and involve radiation exposure and, as a result, many women put off getting this test, and do not receive screening for early detection of breast cancer. Mammograms are not available in rural and underserved areas and are not easily accessible. Without screening, there is a risk of not finding cancer until it is already in its later stages, and the chance of cure is reduced. This study is collecting blood samples from women aged 40 and above who are presenting for a mammogram. Follow-ups are conducted by contacting the patient as to their cancer diagnosis (or lack thereof) every 6 months for a maximum of one year. The primary objective of this study is to confirm the clinical accuracy of the TriNetra-Breast device for detecting breast cancer. We hope that the TriNetra blood-based cancer screening test will prove effective in detecting cancer with a blood test that is convenient and widely applicable. This will allow the implementation of TriNetra into everyday medicine, especially for use on high-risk patients, who would otherwise be subjected to harmful radiation exposure from mammograms. Thus, early diagnoses will become more widely applicable and improve the chances of survival for women at risk for breast cancer
